Table 1. Patient characteristics (n=187).
Feature | Frequency (n, %) |
---|---|
Gender (n=186) | |
Male | 92 (49.5) |
Female |
94 (50.5) |
Age (years) | |
Mean (min, max) |
68.1 (35–93) |
Tumor size (mm) | |
Mean (min, max) |
4.5 (1–12) |
Histological subtype (n=187) | |
Non-mucinous | 163 (87.2) |
Mucinous |
24 (12.8) |
Tumor location (n=186) | |
Left-side | 115 (61.8) |
Right-side | 45 (24.2) |
Rectum |
26 (14.0) |
Tumor grade (n=187) | |
G1–2 | 118 (63.1) |
G3 |
69 (36.9) |
pT (n=187) | |
pT1–2 | 49 (26.2) |
pT3–4 |
138 (73.8) |
pN (n=187) | |
pN0 | 95 (50.8) |
pN1–2 |
92 (49.2) |
pM (n=186) | |
pM0 | 169 (90.9) |
pM1 |
17 (9.1) |
V (n=187) | |
V+ | 29 (15.5) |
V− |
158 (84.5) |
L (n=187) | |
L+ | 75 (40.1) |
L− |
112 (59.9) |
Tumor budding (n=187) | |
Low-grade | 105 (56.2) |
High-grade |
82 (43.9) |
Tumor growth pattern (n=187) | |
Infiltrating | 134 (71.7) |
Pushing |
53 (28.3) |
Post-operative therapy (n=187) | |
None | 69 (36.9) |
Chemo | 75 (40.1) |
Chemo+radio | 42 (22.5) |
Radio |
1 (0.5) |
Mismatch repair status (n=186) | |
Proficient | 173 (93.0) |
Deficient |
13 (7.0) |
KRAS mutation (codon 12/13), (n=171) | |
Wild type | 113 (66.1) |
Mutated |
58 (33.9) |
Survival time (n=186) | |
Months | 47 (35–58) |